Cortica, the leading physician-led autism services company that treats the whole child and helps children with developmental differences thrive, has closed a $75 million financing and acquired Springtide Child Development. The funding round was led by Deerfield Management and Optum Ventures. In the acquisition of Springtide, a premier integrated data-driven autism provider in the Northeast, Springtide's investors have rolled their equity entirely into Cortica. Cortica has also acquired the Melmed Center, a leading developmental pediatrics clinical and research group based in Arizona. The company now owns and operates 23 integrated autism centers across the country.

Additional new investors include RA Capital Management and Echo Health Ventures, alongside existing Cortica investors Longitude Capital, .406 Ventures, Questa Capital, Ajax Health, Aperture Venture Partners, and the Autism Impact Fund.

Cortica's mission is to design and deliver life changing care - one child, one family, one community at a time. Cortica was founded to fix the fragmented journey families typically navigate while seeking diagnoses and therapies for their children. The company seamlessly blends neurology, research-based therapies, and technology into comprehensive care programs. Cortica's coordinated approach leads to best-in-class member satisfaction and empowers families to achieve long-lasting, transformative results.